Altitude sickness market is also known as acute mountain sickness and is caused due to low levels of oxygen at very high altitudes owing to acute exposure to low partial oxygen pressure. Such a kind of sickness is known to occur above 2,500 meters. Specific factors such as sex, age, or physical fitness, are not responsible for increasing a person’s probability to encounter altitude sickness. Certain people are affected while others are less susceptible to it. About 20% of people who ascend above 2,500 meters in a day are known to experience altitude sickness, where children are more susceptible and increasing risk for people under the age of 60 years.
Progression of the condition may lead to potentially fatal situation such as high altitude cerebral (HACE) or pulmonary edema (HAPE). Shortness of breath, associated headache and dehydration are the primary symptoms suggesting altitude sickness. Other symptoms include loss of appetite, weakness and trouble sleeping. This condition can be mistaken with flu, dehydration or hangover. Risk factors for altitude sickness comprise obesity, chronic diseases, abuse of narcotics, heavy alcohol consumption and exertion.
Request Brochure of Altitude Sickness Market Report
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33935
Disorientation, loss of memory, hallucinations, psychotic disorders, coma and loss of co-ordinations are some of the symptoms related to high altitude cerebral edema. Signs of high altitude pulmonary edema include a bubbling sound and feeling of tightness in the chest, impending suffocation at night, confusion and irrational behavior. At high altitudes, some people may even suffer from acute farsightedness.
Geographically, the altitude sickness market can be categorized into four major regions namely North America, Europe, Asia Pacific and Rest of the World. Some of the key players contributing to the global altitude sickness drugs market are Pfizer, Inc., Bayer AG, Mylan, Inc., Teva Pharmaceuticals, and Bristol Laboratories. Manufacturers for portable oxygen chambers, ventilators include Inogen, Smiths Medical, Philips Healthcare, O2Concepts Oxlife, Vygon, Nidek Medical, OSI Systems, Inova Labs, and Teijin.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
